18/11/2024
Some ideas to improve retention and engagement.
"iOAT clients surveyed in Vancouver, Canada, appear to prefer greater autonomy than they currently have in choosing OAT medication type, dosage and treatment schedule. "
https://doi.org/10.1111/add.16620
From the findings:
Most participants were current iOAT clients. Latent class analysis identified two distinct groups of client preferences: (1) autonomous decision-makers (n = 73; 59%) and (2) shared decision-makers (n = 51; 41%). These groups had different preferences for how medication type and dosage were selected. Both groups prioritized access to take-home medication (i.e. carries), the ability to set their own schedule, receiving iOAT in a space they like and having other services available at iOAT clinics. Compared with shared decision-makers, fewer autonomous decision-makers identified as a cis-male/man and reported flexible preferences.
In my view, there is a group, amenable to interventions recommended by health care providers including treatment.
However, there is another group that wants the power to make decisions autonomously. and this group has identifiable characteristics including less likely to identify as a cis-male/man. Clients prioritize attributes of iOAT that empower them with greater autonomy in their addiction care.
Background and Aims Clinical trials support injectable opioid agonist treatment (iOAT) for individuals with opioid use disorder (OUD) for whom other pharmacological management approaches are not wel...
